One of the nice subtleties of the LoBue presentation is on slide 25
Populations/situations in which IGRAs are preferredThis indicates a departure from previous CDC advice which stated that
– testing persons from groups that historically have poor rates of return for TST reading
– testing persons who have received BCG (as a vaccine or for cancer therapy)
the TB skin test is not contraindicated for persons who have been vaccinated with BCG.It would now seem that for BCG vaccinated persons the CDC would prefer that you used an IGRA.
Also on slide 27 Dr LoBue put the skids under the two step process
Routine testing with both TST and an IGRA is not recommendedIt doesnt leave testers with too many options?
